These findings show that BMP2 promotes NSCLC metastasis, indicating that targeting the BMP2 signaling pathway may represent a potential therapeutic strategy for treating patients with metastatic NSCLC. The gene discussed is BMP2; the disease is non-small cell lung carcinoma.